387 related articles for article (PubMed ID: 22212377)
1. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.
Peters BS; Wierzbicki AS; Moyle G; Nair D; Brockmeyer N
Clin Ther; 2012 Jan; 34(1):67-76. PubMed ID: 22212377
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients.
Su TC; Hwang JJ; Huang KC; Chiang FT; Chien KL; Wang KY; Charng MJ; Tsai WC; Lin LY; Vige R; Olivar JE; Tseng CD
J Atheroscler Thromb; 2017 Mar; 24(3):275-289. PubMed ID: 27600795
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
[TBL] [Abstract][Full Text] [Related]
4. Reduction in triglyceride level with N-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: a randomized prospective study.
De Truchis P; Kirstetter M; Perier A; Meunier C; Zucman D; Force G; Doll J; Katlama C; Rozenbaum W; Masson H; Gardette J; Melchior JC
J Acquir Immune Defic Syndr; 2007 Mar; 44(3):278-85. PubMed ID: 17179770
[TBL] [Abstract][Full Text] [Related]
5. Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults.
Oelrich B; Dewell A; Gardner CD
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):350-7. PubMed ID: 21924882
[TBL] [Abstract][Full Text] [Related]
6. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
[TBL] [Abstract][Full Text] [Related]
7. Associations between Omega-3 Index increase and triacylglyceride decrease in subjects with hypertriglyceridemia in response to six month of EPA and DHA supplementation.
Schuchardt JP; Neubronner J; Block RC; von Schacky C; Hahn A
Prostaglandins Leukot Essent Fatty Acids; 2014 Oct; 91(4):129-34. PubMed ID: 25108576
[TBL] [Abstract][Full Text] [Related]
8. Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study.
Domingo P; Fernández I; Gallego-Escuredo JM; Torres F; Gutierrez MDM; Mateo MG; Villarroya J; Giralt M; Vidal F; Villarroya F; Domingo JC
Clin Nutr; 2018 Aug; 37(4):1340-1347. PubMed ID: 28648475
[TBL] [Abstract][Full Text] [Related]
9. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.
Durrington PN; Bhatnagar D; Mackness MI; Morgan J; Julier K; Khan MA; France M
Heart; 2001 May; 85(5):544-8. PubMed ID: 11303007
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial.
Kim CH; Han KA; Yu J; Lee SH; Jeon HK; Kim SH; Kim SY; Han KH; Won K; Kim DB; Lee KJ; Min K; Byun DW; Lim SW; Ahn CW; Kim S; Hong YJ; Sung J; Hur SH; Hong SJ; Lim HS; Park IB; Kim IJ; Lee H; Kim HS
Clin Ther; 2018 Jan; 40(1):83-94. PubMed ID: 29223557
[TBL] [Abstract][Full Text] [Related]
11. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides.
Schwellenbach LJ; Olson KL; McConnell KJ; Stolcpart RS; Nash JD; Merenich JA;
J Am Coll Nutr; 2006 Dec; 25(6):480-5. PubMed ID: 17229894
[TBL] [Abstract][Full Text] [Related]
12. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
13. The effect of n - 3 PUFA/gamma-cyclodextrin complex on serum lipids in healthy volunteers--a randomized, placebo-controlled, double-blind trial.
Kobayashi K; Hamazaki K; Fujioka S; Terao K; Yamamoto J; Kobayashi S
Asia Pac J Clin Nutr; 2007; 16(3):429-34. PubMed ID: 17704023
[TBL] [Abstract][Full Text] [Related]
14. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial.
Mozaffari-Khosravi H; Yassini-Ardakani M; Karamati M; Shariati-Bafghi SE
Eur Neuropsychopharmacol; 2013 Jul; 23(7):636-44. PubMed ID: 22910528
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of omega-3 fatty acid supplementation for the treatment of hypertriglyceridemia in HIV-infected males on highly active antiretroviral therapy.
Carter VM; Woolley I; Jolley D; Nyulasi I; Mijch A; Dart A
Sex Health; 2006 Dec; 3(4):287-90. PubMed ID: 17112442
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized long-term (ORL) study.
Tatsuno I; Saito Y; Kudou K; Ootake J
J Clin Lipidol; 2013; 7(6):615-25. PubMed ID: 24314359
[TBL] [Abstract][Full Text] [Related]
17. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.
Scorletti E; West AL; Bhatia L; Hoile SP; McCormick KG; Burdge GC; Lillycrop KA; Clough GF; Calder PC; Byrne CD
J Hepatol; 2015 Dec; 63(6):1476-83. PubMed ID: 26272871
[TBL] [Abstract][Full Text] [Related]
18. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
19. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
20. Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors.
Dawczynski C; Massey KA; Ness C; Kiehntopf M; Stepanow S; Platzer M; Grün M; Nicolaou A; Jahreis G
Clin Nutr; 2013 Oct; 32(5):686-96. PubMed ID: 23332800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
